#Japan #Tokyo #cancer screening #Renatech #Metal Balance Test

Early Cancer and Cognitive Disorder Risk Assessment in Tokyo

In a groundbreaking move for preventive health, Renatech Co., Ltd., based in Isehara City, Kanagawa, has announced the availability of its innovative screening test, the Metal Balance Test, at the Stem Healer Nihonbashi Clinic in central Tokyo. Starting in October, this test will assess risks related to cancer and mild cognitive impairment (MCI) using just 6mL of blood.

The Metal Balance Test involves a nuanced analysis of 17 trace elements within the blood to provide an objective evaluation of cancer and MCI risk at the time of testing. This offers significant advantages over traditional testing methods, enabling prompt identification of potential health issues.

What is the Metal Balance Test?

The Metal Balance Test is a risk screening procedure that evaluates the balance of trace metal concentrations in the blood. By processing a small amount of blood—only 6mL—medical professionals can quickly ascertain an individual’s risk of various cancers and cognitive impairment.

Key Features of the Metal Balance Test

• - Minimal Blood Draw: The test requires just one blood draw, conducted under strict medical oversight to ensure safety and comfort. The whole process lasts approximately 15 minutes, reducing physical strain.
• - Comprehensive Cancer Risk Analysis: The test can evaluate risks for multiple types of cancers across different anatomical areas, categorized by gender. For men, the evaluation includes risks for lung, stomach, liver, pancreas, colon, and prostate cancers. Meanwhile, women are assessed for lung, stomach, liver, pancreas, colon, breast, cervical, uterine, and ovarian cancers.
• - Thorough MCI Risk Evaluation: In addition to common forms of Alzheimer’s disease, the test comprehensively covers other types including vascular and Lewy body dementia, providing a holistic view of cognitive health.
• - Strong Research Backing: Developed with support from the Ministry of Economy, Trade and Industry’s Go-Tech initiative, the test has undergone rigorous research in collaboration with the Kanagawa and Chiba Prefectural Cancer Centers. Its credibility is further bolstered by patents in nine countries, demonstrating its global recognition.

Registration and Testing Process

Interested individuals can book appointments through the Stem Healer Nihonbashi Clinic, with a clear structure for registration:
1. Application: Patients need to apply approximately three weeks prior to the desired testing date, as paperwork must be completed beforehand.
2. Procedure on the Day: On the appointment day, the process is streamlined due to strict scheduling, allowing the blood draw to be completed quickly.
3. Results Notification: Test results will be mailed to patients approximately five weeks following the blood draw, after receipt of payment.

Important Considerations

• - Fasting Requirements: Patients must refrain from eating or drinking alcohol from the night before. Adequate water intake is encouraged to facilitate blood collection.
• - Age Restrictions: The cancer risk test is designed for individuals aged 20-80, while the MCI risk test targets those aged 50-80. Results for patients outside these age brackets may be considered as reference only.

Location and Contacts

The Stem Healer Nihonbashi Clinic is located at 3-3-1 Nihonbashi Muromachi, Chuo City, Tokyo. It is accessible via the Hanzomon and Ginza lines or a short walk from Shin-Nihonbashi Station.

For those interested in the Metal Balance Test, it is essential to note the availability of testing on Monday and Thursday, excluding holidays. More information and reservations can be made via their website.

Renatech remains committed to enhancing individual health management and disease prevention through advanced medical technology, fostering a community approach towards proactive health. With the introduction of the Metal Balance Test, the company is poised to make significant contributions to public health and wellness in Japan.

Conclusion

The launch of the Metal Balance Test at Stem Healer Nihonbashi Clinic signifies a promising shift towards early diagnosis and preventive healthcare in Japan. By enabling individuals to gain critical insights into their health with minimal discomfort, this development is set to impact thousands of lives positively. Patients are encouraged to take this proactive step in managing their health and well-being.